Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vaneck Pharmaceutical ETF (PPH)

Vaneck Pharmaceutical ETF (PPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 585,847,200
  • Shares Outstanding, K 6,640
  • 60-Month Beta 0.72
  • Price/Earnings ttm 15.43
  • Annual Dividend & Yield 2.31 (2.62%)
  • Most Recent Dividend 0.607 on 07/01/25
  • Management Fee 0.36%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 17.36% ( -0.25%)
  • Historical Volatility 12.43%
  • IV Percentile 70%
  • IV Rank 32.58%
  • IV High 33.54% on 04/08/25
  • IV Low 9.54% on 11/13/24
  • Put/Call Vol Ratio 0.41
  • Today's Volume 38
  • Volume Avg (30-Day) 105
  • Put/Call OI Ratio 10.58
  • Today's Open Interest 6,184
  • Open Int (30-Day) 13,349

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.66 +1.81%
on 06/23/25
91.78 -3.87%
on 06/12/25
-2.19 (-2.42%)
since 06/11/25
3-Month
81.76 +7.91%
on 04/16/25
91.78 -3.87%
on 06/12/25
+6.22 (+7.58%)
since 04/11/25
52-Week
77.67 +13.60%
on 04/09/25
99.51 -11.34%
on 09/03/24
-4.59 (-4.95%)
since 07/11/24

Most Recent Stories

More News
Do Wall Street Analysts Like Cencora Stock?

Cencora has significantly outperformed the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

$SPX : 6,259.75 (-0.33%)
COR : 295.21 (-0.71%)
PPH : 88.23 (-1.26%)
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

VSS : 134.58 (-0.55%)
VXUS : 69.00 (-0.69%)
PPH : 88.23 (-1.26%)
BLCO : 13.88 (-2.25%)
BHC : 6.42 (-3.02%)
Cencora Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Cencora's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's future.

$SPX : 6,259.75 (-0.33%)
COR : 295.21 (-0.71%)
PPH : 88.23 (-1.26%)
Is Wall Street Bullish or Bearish on AbbVie Stock?

Despite AbbVie's underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's future.

$SPX : 6,259.75 (-0.33%)
PPH : 88.23 (-1.26%)
ABBV : 192.45 (-1.31%)
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 25.88 (-1.03%)
IHE : 67.18 (-0.75%)
LLY : 793.01 (+0.30%)
MEDX : 27.83 (-0.78%)
PPH : 88.23 (-1.26%)
THNR : 22.97 (-1.34%)
Winners and Losers: Post-Election Options Analysis

Investors are anticipating which sectors might be most affected by the Trump administration. Brett Friedman, Winhall Risk Analytics/OptionMetrics Contributor takes a look at options data and implied volatility...

XLE : 89.13 (+0.45%)
ITA : 189.78 (+0.60%)
PPH : 88.23 (-1.26%)
^BTCUSD : 117,389.68 (-0.24%)
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink?

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

HON : 235.93 (-0.35%)
$SPX : 6,259.75 (-0.33%)
COR : 295.21 (-0.71%)
PPH : 88.23 (-1.26%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 73.53 (-0.53%)
BE : 25.40 (-1.74%)
CVX : 155.31 (+0.74%)
JPM : 286.86 (-0.46%)
MRK : 83.36 (-0.79%)
IHE : 67.18 (-0.75%)
PPH : 88.23 (-1.26%)
UNH : 304.10 (+1.53%)
PFE : 25.65 (-0.50%)
KBH : 55.60 (-1.03%)
XLE : 89.13 (+0.45%)
XHB : 104.75 (-1.24%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 135.19 (-0.83%)
JNJ : 156.90 (-0.50%)
IHE : 67.18 (-0.75%)
IYH : 56.69 (-1.00%)
PPH : 88.23 (-1.26%)
FTXH : 26.46 (-1.32%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 68.93 (-2.93%)
LLY : 793.01 (+0.30%)
HRTS : 28.84 (-1.50%)
PPH : 88.23 (-1.26%)
THNR : 22.97 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 89.61
2nd Resistance Point 89.07
1st Resistance Point 88.65
Last Price 88.23
1st Support Level 87.69
2nd Support Level 87.15
3rd Support Level 86.73

See More

52-Week High 99.51
Fibonacci 61.8% 91.17
Fibonacci 50% 88.59
Last Price 88.23
Fibonacci 38.2% 86.01
52-Week Low 77.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar